Negotiable: Paramount Recruitment: Head of Bioinformatics Research Services London Paramount are working in partnership with Genomics England to expand their team in order to deliver success Paramount are working in partnership with Genomics England to expand their team in order to with t London, England

Negotiable: Paramount Recruitment: Software Developer - Bioinformatics London Paramount are working in partnership with Genomics England to expand their team in order to deliver success Paramount are working in partnership with Genomics England to expand their team in order to with the 10 London, England

Details upon application: University of Denmark: One PhD position is available at the Department of Bio and Health Informatics (DTU Bioinformatics)..... Denmark (DK)

Degree in Bioinformatics, Data Mining/Data Science or Computer Science (PhD). Candidates with a computational background (PhD) and the desire to get involved in... $40,000 - $60,000 a year
From Indeed - Sun, 22 Oct 2017 13:45:11 GMT - View all Lyon, MS jobs

The IBI will integrate informatics disciplines including bioinformatics, translational bioinformatics, clinical informatics, clinical research informatics,...
From Institute For Biomedical Informatics - Sun, 22 Oct 2017 07:06:06 GMT - View all United States jobs

Job duties are performed in either a Natera office or in the employee’s home office, office space should be private and have Internet access....
From Natera - Fri, 20 Oct 2017 23:47:49 GMT - View all Remote jobs

A Four-year university degree required in Bachelor of Science, Nursing or related healthcare field preferred....
From Natera - Fri, 20 Oct 2017 23:47:48 GMT - View all Remote jobs

The department has outstanding facilities and support, with state-of-the-art core facilities including a world-class bioimaging center, DNA sequencing &...
From University of Delaware - Fri, 20 Oct 2017 22:04:30 GMT - View all Newark, DE jobs

Funding Opportunity RFA-FD-18-003 from the NIH Guide for Grants and Contracts. The Food and Drug Administration announces its intention to accept and consider a single source application for award to the World Health Organization (WHO) for the Building Research Capacity in Global Tobacco Product Regulation Program. The purpose of the Program is to identify, support, develop, conduct, and coordinate research efforts relating to tobacco control laws and rules in foreign countries that will directly inform and support FDAs exercise of its authority to regulate the manufacture, distribution, marketing and sale of tobacco products in the United States. The Program will advance FDA's Center for Tobacco Products' (CTPs) mission by utilizing the World Health Organizations (WHO) Member States expertise and extensive international contacts in global tobacco control, as well as WHO's own programmatic expertise, to inform and support adequate manufacture, distribution and market regulations of tobacco products for the protection of public health in the United States. The Program will also provide a universal public benefit by creating opportunities for collaboration and research development globally, thereby resulting in better-informed and effective tobacco product regulation around the world, and increased knowledge in the public sphere regarding tobacco use and its harms globally.

Funding Opportunity RFA-CA-17-044 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this Funding Opportunity Announcement (FOA) is to create a U24 Coordinating Center that will integrate and facilitate trans-disciplinary research across the Drug Resistance and Sensitivity Centers (DRSCs), established under an earlier released RFA-CA-17-009 for U54 specialized centers. The DRSCs are designed to target the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Establish a network of multi-disciplinary research teams to study mechanisms of tumor resistance and sensitivity and develop innovative anti-cancer therapy strategies. The Coordinating Center to be established under this FOA will facilitate the activities of the DRSCs and help integrate the results of their studies.

Funding Opportunity RFA-CA-17-038 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. This purpose of this FOA is to promote research in colorectal cancer (CRC) screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based approaches.

Funding Opportunity RFA-CA-17-039 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research in colorectal cancer screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based Approaches.

Funding Opportunity PA-18-328 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support investigator-initiated R21 applications that will inform our understanding of the typical and atypical patterns of language and literacy development of dual language learners (DLLs) in the United States. Applicants are encouraged to take advantage of advances in the language sciences and related fields to identify and clarify specific cognitive, linguistic, neurobiological, and sociocultural factors associated with normal and impaired language and literacy acquisition in young DLL populations.

Funding Opportunity PA-18-316 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support investigator-initiated R01 applications that will inform our understanding of the typical and atypical patterns of language and literacy development of dual language learners (DLLs) in the United States. Applicants are encouraged to take advantage of advances in the language sciences and related fields to identify and clarify specific cognitive, linguistic, neurobiological, and sociocultural factors associated with normal and impaired language and literacy acquisition in young DLL populations.

Notice NOT-HS-18-001 from the NIH Guide for Grants and Contracts

Notice NOT-HS-18-002 from the NIH Guide for Grants and Contracts

In relevant field, such as Biochemistry, Bioinformatics, Biophysics, Computer Science, Statistics, Data Science, Chemistry, Bioengineering, or Biology.... $81,000 a year
From Signature Science, LLC - Fri, 20 Oct 2017 09:00:05 GMT - View all Austin, TX jobs

Funding Opportunity PAR-18-405 from the NIH Guide for Grants and Contracts. The National Heart, Lung, and Blood Institute (NHLBI) Program Project Grant (P01) supports research related to fundamental processes and diseases of the heart, blood and lymphatic vessels, lungs, and blood, including transfusion medicine, blood resources, and sleep disorders other programs including implementation science, health disparities, and translation research that address the mission of the Institute. This FOA requires a minimum of three interrelated research projects that investigate a complex biomedical theme or research question. The projects may be supported by core units, if justified, to facilitate economy of effort, space, and equipment. The NHLBI provides support for Program Project Grants (PPGs) in the belief that collaborative research efforts can accelerate the acquisition of knowledge more effectively than a simple aggregate of research projects that have no interaction or thematic integration. NHLBI is particularly interested in encouraging new scientific directions in PPGs. Use of the P01 activity code is viewed as an opportunity to attract scientists who have not traditionally been supported by the NHLBI. Further, the PPG environment presents an opportunity for emerging scientific leaders to gain insight into how to lead a successful scientific Program, and applicants will have the opportunity to include a project led by an Early Stage Investigator (ESI). All projects in the Program must be interrelated and have objectives that address a central theme within the scientific mandate of the NHLBI.

Funding Opportunity RFA-GM-18-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide opportunities for eligible U.S. small business concerns (SBCs), in collaboration with academic partners, to conduct research to develop, implement, and test a comprehensive program for promoting biomedical entrepreneurship, technology (tech) transfer, management, small business finance, and other business skills needed to move basic discoveries and technologies out of the lab and into commercial products that improve patient care and enhance human health. This would be done by regional tech transfer accelerator hubs created by the awardee SBCs in partnership with academic institutions in Institutional Development Award (IDeA) states (https://www.nigms.nih.gov/Research/CRCB/IDeA/Pages/default.aspx). Each accelerator hub program will be expected to serve a network of several institutional sites across the IDeA states in one of the four regions where the academic partners are located. The goal of this FOA is to enhance the capacity to move scientific results from academic institutions into commercialization and promote a sustainable culture of biomedical entrepreneurship within IDeA states. The product of the funded research will be educational tools i.e., curricula, texts, webinars resulting from the development and testing of research accelerator models. It is anticipated that the educational tools developed under this FOA will be licensed or sold to other institutions that wish to create accelerator hubs.

Funding Opportunity RFA-CA-17-035 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic, multidimensional tumor ecosystem. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases.